|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1983-7-8
|
|
pubmed:abstractText |
29 patients were treated with intravesical adriamycin-instillations after transurethral resection of non-infiltrating bladder tumor. 50 mg Adriblastin were administered every four weeks during one year. In no case there were severe side-effects. Endoscopic controls were performed every three months. 12-28 months after beginning of therapy 6 recurrences (20,7%) were noted.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0015-8178
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
31
|
|
pubmed:volume |
101
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
535-40
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:6852720-Adult,
pubmed-meshheading:6852720-Aged,
pubmed-meshheading:6852720-Doxorubicin,
pubmed-meshheading:6852720-Humans,
pubmed-meshheading:6852720-Male,
pubmed-meshheading:6852720-Middle Aged,
pubmed-meshheading:6852720-Neoplasm Recurrence, Local,
pubmed-meshheading:6852720-Neoplasm Staging,
pubmed-meshheading:6852720-Urethra,
pubmed-meshheading:6852720-Urinary Bladder,
pubmed-meshheading:6852720-Urinary Bladder Neoplasms
|
|
pubmed:year |
1983
|
|
pubmed:articleTitle |
[Drug prevention of recurrence in bladder tumors. Intravesical adriblastin instillation following transurethral resection of non-infiltrating bladder tumors].
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
